Compounds > fulvestrant
Page last updated: 2024-08-26

fulvestrant and Allodynia

fulvestrant has been researched along with Allodynia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, RY; Ding, Y; Gan, YH; Meng, Z; Wang, XD; Zhang, P1
Araldi, D; Ferrari, LF; Green, P; Levine, JD1
Caaveiro, JMM; Egashira, N; Ito, M; Tozaki-Saitoh, H; Tsuda, M; Yamamoto, S; Yamashita, T1
Kondo, D; Kurihara, T; Saegusa, H; Tanabe, T; Yabe, R; Zong, S1
Brandt, MR; Cummons, TA; Harris, HA; Leventhal, L; Piesla, MJ; Rogers, KE1
Dina, OA; Goswami, C; Hucho, T; Kuhn, J; Levine, JD; Suckow, V1

Other Studies

6 other study(ies) available for fulvestrant and Allodynia

ArticleYear
Estradiol upregulates voltage-gated sodium channel 1.7 in trigeminal ganglion contributing to hyperalgesia of inflamed TMJ.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Animals; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrous Cycle; Female; Freund's Adjuvant; Fulvestrant; Gene Expression Regulation; Genes, Reporter; Hyperalgesia; Luciferases; NAV1.7 Voltage-Gated Sodium Channel; Nociception; Ovariectomy; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Temporomandibular Joint; Temporomandibular Joint Dysfunction Syndrome; Trigeminal Ganglion

2017
Age-Dependent Sexual Dimorphism in Susceptibility to Develop Chronic Pain in the Rat.
    Neuroscience, 2018, 09-01, Volume: 387

    Topics: Aging; Animals; Chronic Pain; Dinoprostone; Female; Fulvestrant; Hyperalgesia; Male; Rats; Repetition Priming; Sex Characteristics; Tumor Necrosis Factor-alpha

2018
New pharmacological effect of fulvestrant to prevent oxaliplatin-induced neurodegeneration and mechanical allodynia in rats.
    International journal of cancer, 2019, 10-15, Volume: 145, Issue:8

    Topics: Animals; Cell Line; Fulvestrant; Hybridomas; Hyperalgesia; Male; Mice; Neurons; Neuroprotective Agents; Oxaliplatin; Peripheral Nervous System Diseases; Rats, Sprague-Dawley

2019
Progesterone receptor antagonist is effective in relieving neuropathic pain.
    European journal of pharmacology, 2006, Jul-10, Volume: 541, Issue:1-2

    Topics: Analgesics; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Hot Temperature; Hyperalgesia; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Neuralgia; Pain; Pain Measurement; Progesterone; Receptors, Progesterone; Spinal Nerves

2006
An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain.
    European journal of pharmacology, 2006, Dec-28, Volume: 553, Issue:1-3

    Topics: Animals; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor beta; Fulvestrant; Hot Temperature; Hyperalgesia; Inflammation; Male; Oxazoles; Pain; Rats; Rats, Sprague-Dawley

2006
GPR30 estrogen receptor agonists induce mechanical hyperalgesia in the rat.
    The European journal of neuroscience, 2008, Volume: 27, Issue:7

    Topics: Animals; Cells, Cultured; Cyclopentanes; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Hyperalgesia; Male; Physical Stimulation; Protein Kinase C-epsilon; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled

2008